Delic Labs President and CSO Dr. Markus Roggen to Discuss the Importance of R&D for Business Growth at MJBizCon

October 27, 2022

Dr. Markus Roggen, President and Chief Science Officer for Delic Labs, will participate in a panel discussion about building scientific trust and using research and development to differentiate a brand and maximize revenues…

Ketamine Wellness Centers Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

September 29, 2022

KWC will serve more patients than any other ketamine therapy provider with addition of Medicare, cements status as nation’s largest ketamine clinic network in the U.S. Medicare coverage will be available for patients in eight cities with more to come

KWC Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO® Coverage

September 22, 2022

Nation’s Largest Ketamine Therapy Provider to Offer FDA-Approved Esketamine Nasal Spray to Veterans at Nine KWC Clinics

Delic Corp to Present on Strategy and Expansion of Nation’s Largest Ketamine Clinic Network at H.C. Wainwright Annual Global Investment Conference

September 8, 2022

Matt Stang, executive chairman of Delic, will discuss the company’s efforts to grow the clinic footprint, accept a wider selection of insurance options, and its strategic outlook for the remainder of the year

Delic Executive Chairman Matt Stang Named to World Biz Magazine's Top 100 CEOs in Innovation

September 7, 2022

World Biz Magazine’s Top 100 CEOs in Innovation list recognizes individuals who exhibit exceptional leadership and vision while making invaluable contributions to their industries.

Delic Announces Postponement of Meet Delic Conference

September 6, 2022

Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas. Tickets purchased for Meet Delic 2022 will be honored at next year’s event

Delic Announces Two Key Executive Appointments

August 16, 2022

Matt Stang, Co-founder and CEO of Delic, and Kevin Nicholson, COO of Delic, have been elevated to Executive Chairman and Chief Executive Officer, respectively.

Delic Completes Offerings of Debentures

July 29, 2022

Delic Holdings Corp a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022

Delic 2021 Revenue Shows Strong Growth as Nation’s Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services

July 21, 2022

Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon

Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year

July 20, 2022

The Cannabis Scientist Power List is an annual recognition of the most important innovators within the cannabis industry. Dr. Roggen has been named to the list for the third consecutive year.

Delic Corp uses cookies to
ensure you get the best experience
on our website. View our Privacy
Policy for more information.